Medication Misconceptions II

Friday, February 7, 2020 - 3:45-5:00 pm
 
UAN: 0107-9999-20-036-L01-P
0.125 CEU/1.25 hr
 
This course offers brief presentations on topics where recent practice has changed or study findings have challenged what was once considered “standard of care”. Learn how low you can safely go with LDL levels and more in these short, practical presentations.
 
Learning Objectives
Upon successful completion of this application-based CPE activity, participants should be able to:
 
1. Review current literature for safety and efficacy of using lipid lowering agents to decrease LDL to very low levels.
2. Outline new evidence related to the use of dapagliflozin for patients with heart failure with or without diabetes.
3. Compare and contrast prescription cannabidiol extract (Epidiolex) with cannabis products available from dispensaries.

Emily Van Klompenburg
Emily Van Klompenburg, PharmD, BCACP

Assistant Professor of Pharmacy Practice
South Dakota State University College of Pharmacy and Allied Health Professions
Sioux Falls, SD


Zachary Pape

Zachary Pape, PharmD, BCACP

Associate Professor of Clinical Sciences
Medical College of Wisconsin School of Pharmacy
Milwaukee, WI

James Ray

Emily Neddermeyer, PharmD, BCACP

Clinical Pharmacy Specialist, Neurology
University of Iowa Health Care
Iowa City, IA
 

Anna Pedersen
Anna Pedersen, PharmD, AAHIVP
Clinical Pharmacist
Park Nicollet
St. Louis Park, MN